Close
4

Quotient Sciences Quotient Sciences

X

Find Deutetrabenazine manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

DIGITAL CONTENT

Blog #PharmaFlow

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

Looking for 1392826-25-3 / Deutetrabenazine API manufacturers, exporters & distributors?

Deutetrabenazine manufacturers, exporters & distributors 1

82

PharmaCompass offers a list of Deutetrabenazine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Deutetrabenazine manufacturer or Deutetrabenazine supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Deutetrabenazine manufacturer or Deutetrabenazine supplier.

PharmaCompass also assists you with knowing the Deutetrabenazine API Price utilized in the formulation of products. Deutetrabenazine API Price is not always fixed or binding as the Deutetrabenazine Price is obtained through a variety of data sources. The Deutetrabenazine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Deutetrabenazine

Synonyms

Dutetrabenazine, P341g6w9nb, Sd-809, (3rs,11brs)-9,10-di((2h3)methoxy)-3-(2-methylpropyl)-1,3,4,6,7,11b-hexahydro-2h-benzo(a)quinolizin-2-one, 2h-benzo(a)quinolizin-2-one, 1,3,4,6,7,11b-hexahydro-9,10-di(methoxy-d3)-3-(2-methylpropyl)-, (3r,11br)-rel-, Sd809

Cas Number

1392826-25-3

Unique Ingredient Identifier (UNII)

P341G6W9NB

About Deutetrabenazine

Deutetrabenazine is a novel, highly selective vesicular monoamine transporter 2 (VMAT2) inhibitor indicated for the management of chorea associated with Huntingtons disease. It is a hexahydro-dimethoxybenzoquinolizine derivative and a deuterated [DB04844]. The presence of deuterium in deutetrabenazine increases the half-lives of the active metabolite and prolongs their pharmacological activity by attenuating CYP2D6 metabolism of the compound. This allows less frequent dosing and a lower daily dose with improvement in tolerability. Decreased plasma fluctuations of deutetrabenazine due to attenuated metabolism may explain a lower incidence of adverse reactions associated with deutetrabenazine. Deutetrabenazine is a racemic mixture containing RR-Deutetrabenazine and SS-Deutetrabenazine. Huntington's disease (HD) is a hereditary, progressive neurodegenerative disorder characterized by motor dysfunction, cognitive decline, and neuropsychiatric disturbances that interfere with daily functioning and significantly reduce the quality of life. The most prominent physical symptom of HD that may increase the risk of injury is chorea, which is an involuntary, sudden movement that can affect any muscle and flow randomly across body regions. Psychomotor symptoms of HD, such as chorea, are related to hyperactive dopaminergic neurotransmission. Deutetrabenazine depletes the levels of presynaptic dopamine by blocking VMAT2, which is responsible for the uptake of dopamine into synaptic vesicles in monoaminergic neurons and exocytotic release. As with other agents for the treatment of neurodegenerative diseases, deutetrabenazine is a drug to alleviate the motor symptoms of HD and is not proposed to halt the progression of the disease. In clinical trials of patients with HD, 12 weeks of treatment of deutetrabenazine resulted in overall improvement in mean total maximal chorea scores and motor signs than placebo. It was approved by FDA in April 2017 and is marketed under the trade name Austedo as oral tablets.

Deutetrabenazine Manufacturers

A Deutetrabenazine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Deutetrabenazine, including repackagers and relabelers. The FDA regulates Deutetrabenazine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Deutetrabenazine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Deutetrabenazine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Deutetrabenazine Suppliers

A Deutetrabenazine supplier is an individual or a company that provides Deutetrabenazine active pharmaceutical ingredient (API) or Deutetrabenazine finished formulations upon request. The Deutetrabenazine suppliers may include Deutetrabenazine API manufacturers, exporters, distributors and traders.

click here to find a list of Deutetrabenazine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Deutetrabenazine USDMF

A Deutetrabenazine DMF (Drug Master File) is a document detailing the whole manufacturing process of Deutetrabenazine active pharmaceutical ingredient (API) in detail. Different forms of Deutetrabenazine DMFs exist exist since differing nations have different regulations, such as Deutetrabenazine USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Deutetrabenazine DMF submitted to regulatory agencies in the US is known as a USDMF. Deutetrabenazine USDMF includes data on Deutetrabenazine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Deutetrabenazine USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Deutetrabenazine suppliers with USDMF on PharmaCompass.

Deutetrabenazine WC

A Deutetrabenazine written confirmation (Deutetrabenazine WC) is an official document issued by a regulatory agency to a Deutetrabenazine manufacturer, verifying that the manufacturing facility of a Deutetrabenazine active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Deutetrabenazine APIs or Deutetrabenazine finished pharmaceutical products to another nation, regulatory agencies frequently require a Deutetrabenazine WC (written confirmation) as part of the regulatory process.

click here to find a list of Deutetrabenazine suppliers with Written Confirmation (WC) on PharmaCompass.

Deutetrabenazine NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Deutetrabenazine as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Deutetrabenazine API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Deutetrabenazine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Deutetrabenazine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Deutetrabenazine NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Deutetrabenazine suppliers with NDC on PharmaCompass.

Deutetrabenazine GMP

Deutetrabenazine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Deutetrabenazine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Deutetrabenazine GMP manufacturer or Deutetrabenazine GMP API supplier for your needs.

Deutetrabenazine CoA

A Deutetrabenazine CoA (Certificate of Analysis) is a formal document that attests to Deutetrabenazine's compliance with Deutetrabenazine specifications and serves as a tool for batch-level quality control.

Deutetrabenazine CoA mostly includes findings from lab analyses of a specific batch. For each Deutetrabenazine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Deutetrabenazine may be tested according to a variety of international standards, such as European Pharmacopoeia (Deutetrabenazine EP), Deutetrabenazine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Deutetrabenazine USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY